First Page | Meta Content | |
---|---|---|
Document Date: 2012-12-14 16:15:01Open Document File Size: 38,93 KBShare Result on FacebookCityOrlando / Washington / D.C. / Cleveland / /CompanyJanssen Pharmaceutica L.P. / HYSICIANSJ P OSTGRADUATE PRESS / PHYSICIANS POSTGRADUATE PRESS INC. / /CountryUnited States / / /FacilityUniversity Hospitals / Heathcote / APA Institute of Psychiatric Services / /IndustryTermtreatment of conduct disorder / treatment of pediatric neuropsychiatric disorders / /MedicalConditionconduct disorder / nonpsychotic psychiatric disorders / ADHD / aggressive disruptive behavior disorder / indigestion / schizophrenia / headache / disruptive behavior disorder / Tourette’s disorders / chronic tic / anxiety disorders / patient’s restlessness / Nosebleed / autistic disorder / rare childhood schizophrenia / attention-deficit/ hyperactivity disorder / oppositional defiant disorder / movement disorders / obesity / acute drug-induced movement disorders / eating disorders / disruptive behavior disorders / delirium / restlessness / neuropsychiatric disorders / Children With Oppositional Defiant Disorder / each syndrome / comorbid disorders / pediatric neuropsychiatric disorders / depression / aggressive disruptive behavior disorders / particularly aggressive behavior disorders / recalcitrant schizophrenia / pervasive developmental disorders / attention-deficit/hyperactivity disorder / hyperprolactinemia / /MedicalTreatmentpharmacotherapy / /OrganizationDepartment of Psychiatry / APA Institute of Psychiatric Services / U.S. Food and Drug Administration / /PersonRobert L. Findling Dosing / Robert L. Findling / /Positionauthor / Corresponding author / /Productolanzapine / Risperdal / Seroquel / risperidone / Geodon / Abilify / CONCLUSION Atypical / Zyprexa / /ProvinceOrStateOhio / /RadioStationAm 1998 / /Technologypharmacokinetics / Pharmacodynamics / /SocialTag |